We’re Here to Help
The New Jersey Pharmacists Association is working diligently to ensure we provide the most up-to-date and useful information for our members and our community at large. Please utilize the resources below to ensure you and your patients are best prepared for the continually changing status of COVID-19. We've also opened a pharmacist relief network in anticipation of staffing shortages that may arise in response to the crisis. Please see the sign-up form at the bottom of this page. If you are experiencing staffing shortages and would like access to this resource please reach out to Samantha Miller at smiller@njpharma.org. Please do not hesitate to reach out with any questions or concerns you may have. Thank you for your service as healthcare providers, we are here to support you as we navigate this unprecendented event.
General Resources for Practicing Pharmacists
Click Here
- April 30th, 2020: FDA cautions against use of hydroxychloroquine or chloroquine for COVID-19 outside of the hospital setting or a clinical trial due to risk of heart rhythm problems
- April 28th, 2020: Guidance for Facilities and Providers Performing COVID-19 Testing
- April 27th, 2020: PPE Preservation Best Practices
- April 27th, 2020: Coronavirus (COVID-19) Update: FDA Reiterates Importance of Close Patient Supervision for ‘Off-Label’ Use of Antimalarial Drugs to Mitigate Known Risks, Including Heart Rhythm Problems
- April 27th, 2020: COVID-19 Treatment Guidelines
- April 21st, 2020: FDA approved an Abbreviated New Drug Application (ANDA) for Albuterol Sulfate Inhalation Solution 0.021% and 0.042% for the relief of bronchospasm in patients 2 to 12 years of age with asthma
- April 21st, 2020: FDA Authorizes First Test for Patient At-Home Sample Collection
- April 16th, 2020: FEMA Distribution of Stock Pile
- April 15th, 2020: WHO Strategic Preparedness and Response Plan
- April 9th, 2020: CDC Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens
- April 9th, 2020: CDC Decontamination and Reuse of Filtering Facepiece Respirators
- April 7th, 2020: CMS Clinician Letter
- April 6th, 2020: CDC Training Guidance
- April 2nd, 2020: CDC Guidance on Asthma Management in Conjunction with COVID-19 Prevention
- April 2nd, 2020: CDC Guidance For Test Collection
- April 1st, 2020: CDC Printable Fact Sheets
- March 31st, 2020: General Breakdown of Types of COVID-19 Testing
- March 31st, 2020: CDC Interim Guidance for Outpatient Hemodialysis Facilities
- March 30th, 2020: FDA Guidance on Device Classification of Gowns, Gloves, and Other Apparel
- March 30th, 2020: DEA Oral Schedule II Prescription Insurance Guidance
- March 29th, 2020: FDA Guidance on Device Classification of Sterilizers, Disinfectant Devices, and Air Purifiers
- March 24th, 2020: ASHP Drug Shortage Information
- March 24th, 2020: NJ DHS Opioid Treatment Guidance
- March 21st, 2020: ASHP Evidence for Treatment Breakdown
- March 20th, 2020: Johns Hopkins General FAQ
- March 20th, 2020: NJ State-At-Home Order Announcement
- March 20th, 2020: Hydroxychloroquine Supply Information
- March 20th, 2020: BOP Press Release on Out-Of-State Healthcare Provider Waiver
- March 18th, 2020: USP Response to Shortages of Garb and Personal Protective Equipment (PPE)
- March 17th, 2020: Information on Ibuprofen
- March 17th, 2020: CDC FAQ Page
- March 17th, 2020: Expanded Telehealth Benefits for Medicare Beneficiaries
- March 16th, 2020: NJ Governor's Statement on COVID-19
- March 15th, 2020: CDC Case Update
- March 11th 2020: WHO Director Opening Remarks
- March 9th, 2020: NJDOH Case Risk Information
- March 9th, 2020: NJDOH Retrospective Exposure Assessment
- State of New Jersey Official COVID-19 Website
- New Jersey Department of Health COVID-19 Dashboard
- NIOSH COVID-19 Resource Page
- HRSA Resources
Resources for Consultant Pharmacists
Click Here
- April 14th, 2020: CMS Guidance for LTC Transfers
- April 6th, 2020: NJDOH Long Term Care Facility Guidance
- April 6th, 2020: NJDOH Nursing Home & Post-Acute Care Outbreak Management
- March 20th, 2020: CMS Prioritization of Survey Activities
- March 20th, 2020: NJDOH LTC Recommendations
- March 13th, 2020: CDC LTC Facility Guidance
- March 13th, 2020: CMS Guidance Document
- March 10, 2020: CMS Medicare Guidance
- March 5th, 2020: ASCP Guidance
- May 1st, 2006: CDC Pandemic Preparation Guidance
Resources for Compounding Pharmacists
Click Here
- April 10, 2020: Temporary PPE Policy for Sterile Compounding
- March 26th: FDA Statement on Manufacture of Alcohol for Incorporation Into AlcoholBased Hand Sanitizer Products
- March 25th, 2020: USP Compounding of Alcohol-Based Hand Sanitizers Guidance
- March 20th, 2020: CMS Face-To-Face Services Guidance
- March 18th, 2020: USP Response to Shortages of Garb and Personal Protective Equipment (PPE)
- NJDCA USP 800 Guidance
- NJDCA Community Compounding Guidance
- March 11th, 2020: FDA Medical Device Guidance
- March 2020: FDA Temporary Compounding Regs for Sanitizer
Resources for Hospital Pharmacists
Click Here
- April 22nd, 2020: Guidance for Licensed Independent Freestanding Emergency Departments (EDs) to Participate in Medicare and Medicaid during the COVID-19 Public Health Emergency
- April 17th, 2020: NJDOH Field Hospital Fact Sheet
- April 9th, 2020: CDC Considerations for Inpatient Obstetric Healthcare Settings
- April 8th, 2020: CMS Infection Control and Prevention Guidance
- April 8th, 2020: CMS Medical Treatment and Labor Act Requirements and Implications
- April 3rd, 2020: CDC PPE Use Factsheet
- April 3rd, 2020: CDC Interim Prevention and Control Recommendations for Confirmed or Suspected COVID-19 Cases
- March 31st, 2020: CMS Letter to the White House
- March 30th, 2020: CMS Regulatory Guidance for Healthcare Systems
- March 30th, 2020: NJ DOH Priority Action for Post-Acute Care Facilities Guidance
- March 30th, 2020: NJ DOH Guidelines for Diagnosed/Exposed Healthcare Personnel Returning to Work
- March 29th, 2020: WHO Essential Medication Guidelines
- March 24th, 2020: ASHP Drug Shortage Information
- March 23rd, 2020: Stewardship of Off-Label Treatments for COVID-19 Guidance
- March 22nd, 2020: FDA Press Release - Access to Crucial Medical Supplies
- March 21st, 2020: ASHP Evidence for Treatment Breakdown
- March 21st, 2020: CDC Therapeutic Options
- March 19th: ASHP Pandemic Assessment Tool
- March 18th, 2020: USP Response to Shortages of Garb and Personal Protective Equipment (PPE)
- American Society of Health System Pharmacists COVIF-19 Resource Page
- NIOSH COVID-19 Resource Page
Resources for Community Pharmacists
Click Here
- April 17th, 2020: CDC Updated Considerations for Pharmacies
- April 14th, 2020: NJDCA Guidance for Remote Processing
- April 3rd, 2020: CDC Face Covering Guidance
- March 31st, 2020: WHO Immunization ActivitiesDuring a Pandemic Guidance
- March 31st, 2020: CMS COVID-19 Prescription Drug FAQ
- March 30th, 2020: DHS Protocol for the use of Investigational Drugs for the Treatment of COVID-19
- March 20th, 2020: NCPA Notice on Pharmacists as Front Line Providers
- March 18th, 2020: USP Response to Shortages of Garb and Personal Protective Equipment (PPE)
- March 16th, 2020: COVID-19 in Retail Settings
- NCPA Resources
- March 13th, 2020: NJDCA Community Pharmacy Guidance
- March 6th, 2020: President Signs Bill Outlining Role of Pharmacists
- March 5th, 2020: How to Mitigate Drug Shortages
- March 2, 2020: NCPA Official Policy Memo
Official Press Releases
Click Here
- May 11th, 2020: FEMA Crisis Counseling Program Fact Sheet
- April 9th, 2020: HHS statement on authorizing pharmacists to administer COVID tests
- April 9th, 2020: FDA Warning regarding chlorine dioxide fraudulent products for COVID 19
- April 7th, 2020: DCA Administrative Order 2020-03
- April 3rd, 2020: CMS Notification of PDE Prescriber ID Editing and State Emergencies
- March 27th, 2020: FDA Notice on Supply of Ventilators and Respirators for Protection of Healthcare Workers and Patients
- March 26th, 2020: CMS News Alert
- March 24th, 2020: FDA Daily Roundup
- March 22nd, 2020: FDA Press Release - Access to Crucial Medical Supplies
- March 20th, 2020: DEA Early Refill Guidance
- March 20th, 2020: NJ Stay-At-Home Order Announcement
- March 20th, 2020: BOP Press Release on Out-Of-State Healthcare Provider Waiver